Bloomberg Podcasts
@bloombergpodcasts·503K subscribers·32.4K videos
Thousands Claim A Blockbuster Drug Gave Them Cancer | The Big Take
Posted
February 15, 2023
Views
618
Likes
6
Engagement
0.97%
February 15, 2023
618
6
0.97%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
27:58Now PlayingIn 2020, the enormously popular heartburn medication Zantac was pulled from store shelves after samples were found to contain the probable carcinogen NDMA.
The drug has since been re-introduced with a new formula that is considered safe to use as directed.
But tens of thousands of people who took the old version of the drug, made with the active ingredient ranitidine, are now suing Zantac’s maker, then called Glaxo and now known as GSK. They claim the medication gave them cancer and are seeking compensation. The company is pushing back, saying there is no conclusive evidence or scientific consensus that ranitidine can degrade and form NDMA in harmful amounts under normal conditions.
Reporters Anna Edney, Susan Berfield, and Jef Feeley dug into the claims and counterclaims for Bloomberg Businessweek, and they join this episode to talk about Zantac’s rise and fall and where these lawsuits are headed.
And Dr. Jaap Venema, chief science officer at US Pharmacopeia, explains how potential carcinogens get into drugs–and what pharmaceutical companies and government agencies are–and should be–doing to ensure the safety of the medications we take.
Read the story()
Listen to The Big Take podcast every weekday and subscribe to our daily newsletter()
Have questions or comments for Wes and the team? Reach us at bigtake@bloomberg.net (mailto:bigtake@bloomberg.net).
See omnystudio.com/listener () for privacy information.
Each weekday, The Big Take brings you one story—one big, important story. Host Wes Kosova talks to Bloomberg journalists around the world, experts and the people at the center of the news to help you understand what’s happening, what it means and why it matters. Money, politics, the economy and business, energy, the environment, technology—we cover it all on The Big Take.
Subscribe to Bloomberg Podcasts
Listen to more of The Big Take
#Bloomberg #Podcast #TheBigTake
Follow Bloomberg Podcasts on Twitter
Visit our other YouTube channels:
Bloomberg Markets & Finance
Bloomberg Politics
Bloomberg Technology
Quicktake Originals
Quicktake Now
Quicktake Explained
For coverage on news, markets and more
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
